APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thymosin α1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Thymosin α1 Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchThymosin α1 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Thymosin α1 Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Thymosin α1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thymosin α1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Thymosin α1 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Thymosin α1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Thymosin α1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Thymosin α1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Thymosin α1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Thymosin α1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Thymosin α1 include Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, SciClone Pharmaceuticals and Abbiotec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Thymosin α1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Thymosin α1, also provides the sales of main regions and countries. Of the upcoming market potential for Thymosin α1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Thymosin α1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Thymosin α1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Thymosin α1 sales, projected growth trends, production technology, application and end-user industry.

Thymosin α1 Segment by Company

Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical

Shanghai Soho-Yiming Pharmaceuticals

Hybio Pharmaceutical

Hainan Zhonghe Pharmaceutical

Hainan Shuangcheng Pharmaceuticals

SciClone Pharmaceuticals

Abbiotec

Thymosin α1 Segment by Type

Freeze-dried Powder

Injection

Thymosin α1 Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Thymosin α1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thymosin α1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thymosin α1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thymosin α1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Thymosin α1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Thymosin α1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thymosin α1 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Thymosin α1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Freeze-dried Powder Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Thymosin α1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Pharmacies Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. Thymosin α1 Industry Trends Table 9. Thymosin α1 Industry Drivers Table 10. Thymosin α1 Industry Opportunities and Challenges Table 11. Thymosin α1 Industry Restraints Table 12. Global Thymosin α1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Thymosin α1 Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Thymosin α1 Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Thymosin α1 Revenue Market Share by Region (2021-2026) Table 16. Global Thymosin α1 Revenue Market Share by Region (2027-2032) Table 17. Global Thymosin α1 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 18. Global Thymosin α1 Sales by Region (2021-2026) & (kg) Table 19. Global Thymosin α1 Sales by Region (2027-2032) & (kg) Table 20. Global Thymosin α1 Sales Market Share by Region (2021-2026) Table 21. Global Thymosin α1 Sales Market Share by Region (2027-2032) Table 22. Global Thymosin α1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Thymosin α1 Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Thymosin α1 Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Thymosin α1 Sales Market Share by Manufacturers (2021-2026) Table 26. Global Thymosin α1 Sales Price (US$/g) of Manufacturers (2021-2026) Table 27. Global Thymosin α1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Thymosin α1 Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Thymosin α1 Manufacturers, Product Type & Application Table 30. Global Thymosin α1 Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Thymosin α1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Thymosin α1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Thymosin α1 Revenue Market Share by Type (2021-2026) Table 37. Global Thymosin α1 Revenue Market Share by Type (2027-2032) Table 38. Global Thymosin α1 Sales by Type 2021 VS 2025 VS 2032 (kg) Table 39. Global Thymosin α1 Sales by Type (2021-2026) & (kg) Table 40. Global Thymosin α1 Sales by Type (2027-2032) & (kg) Table 41. Global Thymosin α1 Sales Market Share by Type (2021-2026) Table 42. Global Thymosin α1 Sales Market Share by Type (2027-2032) Table 43. Global Thymosin α1 Price by Type (2021-2026) & (US$/g) Table 44. Global Thymosin α1 Price by Type (2027-2032) & (US$/g) Table 45. Global Thymosin α1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Thymosin α1 Revenue Market Share by Application (2021-2026) Table 49. Global Thymosin α1 Revenue Market Share by Application (2027-2032) Table 50. Global Thymosin α1 Sales by Application 2021 VS 2025 VS 2032 (kg) Table 51. Global Thymosin α1 Sales by Application (2021-2026) & (kg) Table 52. Global Thymosin α1 Sales by Application (2027-2032) & (kg) Table 53. Global Thymosin α1 Sales Market Share by Application (2021-2026) Table 54. Global Thymosin α1 Sales Market Share by Application (2027-2032) Table 55. Global Thymosin α1 Price by Application (2021-2026) & (US$/g) Table 56. Global Thymosin α1 Price by Application (2027-2032) & (US$/g) Table 57. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Company Information Table 58. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Business Overview Table 59. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 60. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin α1 Product Portfolio Table 61. Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Recent Development Table 62. Shanghai Soho-Yiming Pharmaceuticals Company Information Table 63. Shanghai Soho-Yiming Pharmaceuticals Business Overview Table 64. Shanghai Soho-Yiming Pharmaceuticals Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 65. Shanghai Soho-Yiming Pharmaceuticals Thymosin α1 Product Portfolio Table 66. Shanghai Soho-Yiming Pharmaceuticals Recent Development Table 67. Hybio Pharmaceutical Company Information Table 68. Hybio Pharmaceutical Business Overview Table 69. Hybio Pharmaceutical Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 70. Hybio Pharmaceutical Thymosin α1 Product Portfolio Table 71. Hybio Pharmaceutical Recent Development Table 72. Hainan Zhonghe Pharmaceutical Company Information Table 73. Hainan Zhonghe Pharmaceutical Business Overview Table 74. Hainan Zhonghe Pharmaceutical Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Hainan Zhonghe Pharmaceutical Thymosin α1 Product Portfolio Table 76. Hainan Zhonghe Pharmaceutical Recent Development Table 77. Hainan Shuangcheng Pharmaceuticals Company Information Table 78. Hainan Shuangcheng Pharmaceuticals Business Overview Table 79. Hainan Shuangcheng Pharmaceuticals Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. Hainan Shuangcheng Pharmaceuticals Thymosin α1 Product Portfolio Table 81. Hainan Shuangcheng Pharmaceuticals Recent Development Table 82. SciClone Pharmaceuticals Company Information Table 83. SciClone Pharmaceuticals Business Overview Table 84. SciClone Pharmaceuticals Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. SciClone Pharmaceuticals Thymosin α1 Product Portfolio Table 86. SciClone Pharmaceuticals Recent Development Table 87. Abbiotec Company Information Table 88. Abbiotec Business Overview Table 89. Abbiotec Thymosin α1 Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. Abbiotec Thymosin α1 Product Portfolio Table 91. Abbiotec Recent Development Table 92. North America Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Thymosin α1 Sales by Type (2021-2026) & (kg) Table 95. North America Thymosin α1 Sales by Type (2027-2032) & (kg) Table 96. North America Thymosin α1 Sales Price by Type (2021-2026) & (US$/g) Table 97. North America Thymosin α1 Sales Price by Type (2027-2032) & (US$/g) Table 98. North America Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Thymosin α1 Sales by Application (2021-2026) & (kg) Table 101. North America Thymosin α1 Sales by Application (2027-2032) & (kg) Table 102. North America Thymosin α1 Sales Price by Application (2021-2026) & (US$/g) Table 103. North America Thymosin α1 Sales Price by Application (2027-2032) & (US$/g) Table 104. North America Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Thymosin α1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Thymosin α1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Thymosin α1 Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 108. North America Thymosin α1 Sales by Country (2021-2026) & (kg) Table 109. North America Thymosin α1 Sales by Country (2027-2032) & (kg) Table 110. North America Thymosin α1 Sales Price by Country (2021-2026) & (US$/g) Table 111. North America Thymosin α1 Sales Price by Country (2027-2032) & (US$/g) Table 112. United States Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 113. Canada Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 114. Mexico Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 115. Europe Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Thymosin α1 Sales by Type (2021-2026) & (kg) Table 118. Europe Thymosin α1 Sales by Type (2027-2032) & (kg) Table 119. Europe Thymosin α1 Sales Price by Type (2021-2026) & (US$/g) Table 120. Europe Thymosin α1 Sales Price by Type (2027-2032) & (US$/g) Table 121. Europe Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Thymosin α1 Sales by Application (2021-2026) & (kg) Table 124. Europe Thymosin α1 Sales by Application (2027-2032) & (kg) Table 125. Europe Thymosin α1 Sales Price by Application (2021-2026) & (US$/g) Table 126. Europe Thymosin α1 Sales Price by Application (2027-2032) & (US$/g) Table 127. Europe Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Thymosin α1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Thymosin α1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Thymosin α1 Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 131. Europe Thymosin α1 Sales by Country (2021-2026) & (kg) Table 132. Europe Thymosin α1 Sales by Country (2027-2032) & (kg) Table 133. Europe Thymosin α1 Sales Price by Country (2021-2026) & (US$/g) Table 134. Europe Thymosin α1 Sales Price by Country (2027-2032) & (US$/g) Table 135. Germany Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 136. France Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 137. U.K. Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 138. Italy Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 139. Russia Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 140. Spain Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 143. Sweden Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 144. Poland Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 145. China Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 146. China Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 147. China Thymosin α1 Sales by Type (2021-2026) & (kg) Table 148. China Thymosin α1 Sales by Type (2027-2032) & (kg) Table 149. China Thymosin α1 Sales Price by Type (2021-2026) & (US$/g) Table 150. China Thymosin α1 Sales Price by Type (2027-2032) & (US$/g) Table 151. China Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 152. China Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 153. China Thymosin α1 Sales by Application (2021-2026) & (kg) Table 154. China Thymosin α1 Sales by Application (2027-2032) & (kg) Table 155. China Thymosin α1 Sales Price by Application (2021-2026) & (US$/g) Table 156. China Thymosin α1 Sales Price by Application (2027-2032) & (US$/g) Table 157. Asia Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Thymosin α1 Sales by Type (2021-2026) & (kg) Table 160. Asia Thymosin α1 Sales by Type (2027-2032) & (kg) Table 161. Asia Thymosin α1 Sales Price by Type (2021-2026) & (US$/g) Table 162. Asia Thymosin α1 Sales Price by Type (2027-2032) & (US$/g) Table 163. Asia Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Thymosin α1 Sales by Application (2021-2026) & (kg) Table 166. Asia Thymosin α1 Sales by Application (2027-2032) & (kg) Table 167. Asia Thymosin α1 Sales Price by Application (2021-2026) & (US$/g) Table 168. Asia Thymosin α1 Sales Price by Application (2027-2032) & (US$/g) Table 169. Asia Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Thymosin α1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Thymosin α1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Thymosin α1 Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 173. Asia Thymosin α1 Sales by Country (2021-2026) & (kg) Table 174. Asia Thymosin α1 Sales by Country (2027-2032) & (kg) Table 175. Asia Thymosin α1 Sales Price by Country (2021-2026) & (US$/g) Table 176. Asia Thymosin α1 Sales Price by Country (2027-2032) & (US$/g) Table 177. Japan Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 178. South Korea Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 179. India Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 180. Australia Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Thymosin α1 Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Thymosin α1 Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Thymosin α1 Sales by Type (2021-2026) & (kg) Table 186. SAMEA Thymosin α1 Sales by Type (2027-2032) & (kg) Table 187. SAMEA Thymosin α1 Sales Price by Type (2021-2026) & (US$/g) Table 188. SAMEA Thymosin α1 Sales Price by Type (2027-2032) & (US$/g) Table 189. SAMEA Thymosin α1 Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Thymosin α1 Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Thymosin α1 Sales by Application (2021-2026) & (kg) Table 192. SAMEA Thymosin α1 Sales by Application (2027-2032) & (kg) Table 193. SAMEA Thymosin α1 Sales Price by Application (2021-2026) & (US$/g) Table 194. SAMEA Thymosin α1 Sales Price by Application (2027-2032) & (US$/g) Table 195. SAMEA Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Thymosin α1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Thymosin α1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Thymosin α1 Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 199. SAMEA Thymosin α1 Sales by Country (2021-2026) & (kg) Table 200. SAMEA Thymosin α1 Sales by Country (2027-2032) & (kg) Table 201. SAMEA Thymosin α1 Sales Price by Country (2021-2026) & (US$/g) Table 202. SAMEA Thymosin α1 Sales Price by Country (2027-2032) & (US$/g) Table 203. Brazil Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 204. Argentina Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 205. Chile Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 206. Colombia Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 207. Peru Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 209. Israel Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 210. UAE Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 211. Turkey Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 212. Iran Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 213. Egypt Thymosin α1 Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Thymosin α1 Distributors List Table 217. Thymosin α1 Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Thymosin α1 Image Figure 2. Global Thymosin α1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thymosin α1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Freeze-dried Powder Image Figure 5. Injection Image Figure 6. Global Thymosin α1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Thymosin α1 Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Online Pharmacies Image Figure 10. Retail Pharmacies Image Figure 11. Global Thymosin α1 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Thymosin α1 Revenue (2021-2032) & (US$ Million) Figure 13. Global Thymosin α1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Thymosin α1 Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Thymosin α1 Revenue Market Share by Region (2021-2032) Figure 16. Global Thymosin α1 Sales (2021-2032) & (kg) Figure 17. Global Thymosin α1 Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 18. Global Thymosin α1 Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Thymosin α1 Sales YoY (2021-2032) & (kg) Figure 20. Europe Thymosin α1 Sales YoY (2021-2032) & (kg) Figure 21. China Thymosin α1 Sales YoY (2021-2032) & (kg) Figure 22. Asia (Excluding China) Thymosin α1 Sales YoY (2021-2032) & (kg) Figure 23. South America, Middle East and Africa Thymosin α1 Sales YoY (2021-2032) & (kg) Figure 24. Global Thymosin α1 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Thymosin α1 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Thymosin α1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Thymosin α1 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Thymosin α1 Revenue Market Share by Type (2021-2032) Figure 30. Global Thymosin α1 Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 31. Global Thymosin α1 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Thymosin α1 Sales Market Share by Type (2021-2032) Figure 33. Global Thymosin α1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Thymosin α1 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Thymosin α1 Revenue Market Share by Application (2021-2032) Figure 36. Global Thymosin α1 Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 37. Global Thymosin α1 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Thymosin α1 Sales Market Share by Application (2021-2032) Figure 39. North America Thymosin α1 Revenue Share by Type (2021-2032) Figure 40. North America Thymosin α1 Sales Share by Type (2021-2032) Figure 41. North America Thymosin α1 Revenue Share by Application (2021-2032) Figure 42. North America Thymosin α1 Sales Share by Application (2021-2032) Figure 43. North America Thymosin α1 Revenue Share by Country (2021-2032) Figure 44. North America Thymosin α1 Sales Share by Country (2021-2032) Figure 45. Europe Thymosin α1 Revenue Share by Type (2021-2032) Figure 46. Europe Thymosin α1 Sales Share by Type (2021-2032) Figure 47. Europe Thymosin α1 Revenue Share by Application (2021-2032) Figure 48. Europe Thymosin α1 Sales Share by Application (2021-2032) Figure 49. Europe Thymosin α1 Revenue Share by Country (2021-2032) Figure 50. Europe Thymosin α1 Sales Share by Country (2021-2032) Figure 51. China Thymosin α1 Revenue Share by Type (2021-2032) Figure 52. China Thymosin α1 Sales Share by Type (2021-2032) Figure 53. China Thymosin α1 Revenue Share by Application (2021-2032) Figure 54. China Thymosin α1 Sales Share by Application (2021-2032) Figure 55. Asia Thymosin α1 Revenue Share by Type (2021-2032) Figure 56. Asia Thymosin α1 Sales Share by Type (2021-2032) Figure 57. Asia Thymosin α1 Revenue Share by Application (2021-2032) Figure 58. Asia Thymosin α1 Sales Share by Application (2021-2032) Figure 59. Asia Thymosin α1 Revenue Share by Country (2021-2032) Figure 60. Asia Thymosin α1 Sales Share by Country (2021-2032) Figure 61. SAMEA Thymosin α1 Revenue Share by Type (2021-2032) Figure 62. SAMEA Thymosin α1 Sales Share by Type (2021-2032) Figure 63. SAMEA Thymosin α1 Revenue Share by Application (2021-2032) Figure 64. SAMEA Thymosin α1 Sales Share by Application (2021-2032) Figure 65. SAMEA Thymosin α1 Revenue Share by Country (2021-2032) Figure 66. SAMEA Thymosin α1 Sales Share by Country (2021-2032) Figure 67. Thymosin α1 Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Thymosin α1 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Freeze-dried Powder
  • Injection
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical
  • Shanghai Soho-Yiming Pharmaceuticals
  • Hybio Pharmaceutical
  • Hainan Zhonghe Pharmaceutical
  • Hainan Shuangcheng Pharmaceuticals
  • SciClone Pharmaceuticals
  • Abbiotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Thymosin α1 Market by Type
  3. 1.2.1 Global Thymosin α1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Freeze-dried Powder
  5. 1.2.3 Injection
  6. 1.3 Thymosin α1 Market by Application
  7. 1.3.1 Global Thymosin α1 Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Retail Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Thymosin α1 Market Dynamics
  1. 2.1 Thymosin α1 Industry Trends
  2. 2.2 Thymosin α1 Industry Drivers
  3. 2.3 Thymosin α1 Industry Opportunities and Challenges
  4. 2.4 Thymosin α1 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Thymosin α1 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Thymosin α1 Revenue by Region
  3. 3.2.1 Global Thymosin α1 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Thymosin α1 Revenue by Region (2021-2026)
  5. 3.2.3 Global Thymosin α1 Revenue by Region (2027-2032)
  6. 3.2.4 Global Thymosin α1 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Thymosin α1 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Thymosin α1 Sales by Region
  9. 3.4.1 Global Thymosin α1 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Thymosin α1 Sales by Region (2021-2026)
  11. 3.4.3 Global Thymosin α1 Sales by Region (2027-2032)
  12. 3.4.4 Global Thymosin α1 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Thymosin α1 Revenue by Manufacturers
  2. 4.1.1 Global Thymosin α1 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Thymosin α1 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Thymosin α1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Thymosin α1 Sales by Manufacturers
  6. 4.2.1 Global Thymosin α1 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Thymosin α1 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Thymosin α1 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Thymosin α1 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Thymosin α1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Thymosin α1 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Thymosin α1 Manufacturers, Product Type & Application
  13. 4.7 Global Thymosin α1 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Thymosin α1 Market CR5 and HHI
  16. 4.8.2 2025 Thymosin α1 Tier 1, Tier 2, and Tier 3
5 Thymosin α1 Market by Type
  1. 5.1 Global Thymosin α1 Revenue by Type
  2. 5.1.1 Global Thymosin α1 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Thymosin α1 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Thymosin α1 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Thymosin α1 Sales by Type
  6. 5.2.1 Global Thymosin α1 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Thymosin α1 Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Thymosin α1 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Thymosin α1 Price by Type
6 Thymosin α1 Market by Application
  1. 6.1 Global Thymosin α1 Revenue by Application
  2. 6.1.1 Global Thymosin α1 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Thymosin α1 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Thymosin α1 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Thymosin α1 Sales by Application
  6. 6.2.1 Global Thymosin α1 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Thymosin α1 Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Thymosin α1 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Thymosin α1 Price by Application
7 Company Profiles
  1. 7.1 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical
  2. 7.1.1 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Company Information
  3. 7.1.2 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Business Overview
  4. 7.1.3 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin α1 Product Portfolio
  6. 7.1.5 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Recent Developments
  7. 7.2 Shanghai Soho-Yiming Pharmaceuticals
  8. 7.2.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
  9. 7.2.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  10. 7.2.3 Shanghai Soho-Yiming Pharmaceuticals Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Soho-Yiming Pharmaceuticals Thymosin α1 Product Portfolio
  12. 7.2.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
  13. 7.3 Hybio Pharmaceutical
  14. 7.3.1 Hybio Pharmaceutical Company Information
  15. 7.3.2 Hybio Pharmaceutical Business Overview
  16. 7.3.3 Hybio Pharmaceutical Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hybio Pharmaceutical Thymosin α1 Product Portfolio
  18. 7.3.5 Hybio Pharmaceutical Recent Developments
  19. 7.4 Hainan Zhonghe Pharmaceutical
  20. 7.4.1 Hainan Zhonghe Pharmaceutical Company Information
  21. 7.4.2 Hainan Zhonghe Pharmaceutical Business Overview
  22. 7.4.3 Hainan Zhonghe Pharmaceutical Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hainan Zhonghe Pharmaceutical Thymosin α1 Product Portfolio
  24. 7.4.5 Hainan Zhonghe Pharmaceutical Recent Developments
  25. 7.5 Hainan Shuangcheng Pharmaceuticals
  26. 7.5.1 Hainan Shuangcheng Pharmaceuticals Company Information
  27. 7.5.2 Hainan Shuangcheng Pharmaceuticals Business Overview
  28. 7.5.3 Hainan Shuangcheng Pharmaceuticals Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hainan Shuangcheng Pharmaceuticals Thymosin α1 Product Portfolio
  30. 7.5.5 Hainan Shuangcheng Pharmaceuticals Recent Developments
  31. 7.6 SciClone Pharmaceuticals
  32. 7.6.1 SciClone Pharmaceuticals Company Information
  33. 7.6.2 SciClone Pharmaceuticals Business Overview
  34. 7.6.3 SciClone Pharmaceuticals Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SciClone Pharmaceuticals Thymosin α1 Product Portfolio
  36. 7.6.5 SciClone Pharmaceuticals Recent Developments
  37. 7.7 Abbiotec
  38. 7.7.1 Abbiotec Company Information
  39. 7.7.2 Abbiotec Business Overview
  40. 7.7.3 Abbiotec Thymosin α1 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Abbiotec Thymosin α1 Product Portfolio
  42. 7.7.5 Abbiotec Recent Developments
8 North America
  1. 8.1 North America Thymosin α1 Market Size by Type
  2. 8.1.1 North America Thymosin α1 Revenue by Type (2021-2032)
  3. 8.1.2 North America Thymosin α1 Sales by Type (2021-2032)
  4. 8.1.3 North America Thymosin α1 Price by Type (2021-2032)
  5. 8.2 North America Thymosin α1 Market Size by Application
  6. 8.2.1 North America Thymosin α1 Revenue by Application (2021-2032)
  7. 8.2.2 North America Thymosin α1 Sales by Application (2021-2032)
  8. 8.2.3 North America Thymosin α1 Price by Application (2021-2032)
  9. 8.3 North America Thymosin α1 Market Size by Country
  10. 8.3.1 North America Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Thymosin α1 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Thymosin α1 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Thymosin α1 Market Size by Type
  2. 9.1.1 Europe Thymosin α1 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Thymosin α1 Sales by Type (2021-2032)
  4. 9.1.3 Europe Thymosin α1 Price by Type (2021-2032)
  5. 9.2 Europe Thymosin α1 Market Size by Application
  6. 9.2.1 Europe Thymosin α1 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Thymosin α1 Sales by Application (2021-2032)
  8. 9.2.3 Europe Thymosin α1 Price by Application (2021-2032)
  9. 9.3 Europe Thymosin α1 Market Size by Country
  10. 9.3.1 Europe Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Thymosin α1 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Thymosin α1 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Thymosin α1 Market Size by Type
  2. 10.1.1 China Thymosin α1 Revenue by Type (2021-2032)
  3. 10.1.2 China Thymosin α1 Sales by Type (2021-2032)
  4. 10.1.3 China Thymosin α1 Price by Type (2021-2032)
  5. 10.2 China Thymosin α1 Market Size by Application
  6. 10.2.1 China Thymosin α1 Revenue by Application (2021-2032)
  7. 10.2.2 China Thymosin α1 Sales by Application (2021-2032)
  8. 10.2.3 China Thymosin α1 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Thymosin α1 Market Size by Type
  2. 11.1.1 Asia Thymosin α1 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Thymosin α1 Sales by Type (2021-2032)
  4. 11.1.3 Asia Thymosin α1 Price by Type (2021-2032)
  5. 11.2 Asia Thymosin α1 Market Size by Application
  6. 11.2.1 Asia Thymosin α1 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Thymosin α1 Sales by Application (2021-2032)
  8. 11.2.3 Asia Thymosin α1 Price by Application (2021-2032)
  9. 11.3 Asia Thymosin α1 Market Size by Country
  10. 11.3.1 Asia Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Thymosin α1 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Thymosin α1 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Thymosin α1 Market Size by Type
  2. 12.1.1 SAMEA Thymosin α1 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Thymosin α1 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Thymosin α1 Price by Type (2021-2032)
  5. 12.2 SAMEA Thymosin α1 Market Size by Application
  6. 12.2.1 SAMEA Thymosin α1 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Thymosin α1 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Thymosin α1 Price by Application (2021-2032)
  9. 12.3 SAMEA Thymosin α1 Market Size by Country
  10. 12.3.1 SAMEA Thymosin α1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Thymosin α1 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Thymosin α1 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Thymosin α1 Value Chain Analysis
  2. 13.1.1 Thymosin α1 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Thymosin α1 Production Mode & Process
  6. 13.2 Thymosin α1 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Thymosin α1 Distributors
  9. 13.2.3 Thymosin α1 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst